Application no. and date | 10178116.9 (espacenet) (Federated) (European Patent Register), 20070607 | Patent/reg. no. and date | DK/EP 2305263, 20120919 | Publication date | 20110406 | Priority no. and date | EP 07109816, 20070607 | EP pub. no. and date |
EP 2305263 20110406 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | NGC/AP/145071 | Inventor | MUTZ, Michael, Mozartstrasse 33
79104 Freiburg, DE, Goncalves, Elisabete, Friedrichstr. 13
4055 Basel, CH, Kalb, Oskar, Oberwilerstrasse 88
4054 Basel, CH, Wirth, Wolfgang, Blauenrainstrasse 3b
4422 Arisdorf, CH | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/506 (2006.01) , A61K 9/16 (2006.01) , A61P 35/02 (2006.01) | Title | Stabiliserede amorfe former af imatinibmesylat | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|